adlainortye.com (ANL) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi

Adlai Nortye Limited - ANL emitenti grafik logotipi

Adlai Nortye Ltd. (ANL) kompaniyasining rejalashtirilgan kapitalni kamaytirish choralari xavotirga sabab bo'lishi mumkin, biroq GURU.Markets terminalining chiziqli grafigidagi uzoq muddatli qarzdorlikning kapitalga nisbati qiymati 0.04 darajasida barqarorlashganini ko'rsatmoqda. Bu onkologiya bozorini egallash uchun buparlisibga tayanilgan garovni tasdiqlaydi. Adlai Nortye Ltd. daromadlari bosh va bo'yin saratoni innovatsion terapiyasi uchun sug'urta to'lovlariga asoslanadi.

Uzoq muddatli qarzning kapitalga nisbati: Adlai Nortye Ltd (ANL) 21.02.2024 - 01.11.2026 uchun

Adlai Nortye Ltd (ANL) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Adlai Nortye Limited|ANL - Maqsadli narxlar grafigi
- bozor kapitallashuvi tafsilotlari:
Bozor kapitallashuvi Adlai Nortye Ltd.|ANL - Korxona qiymati
- emitentning balans qiymati statistikasi:
Bitta aksiya uchun buxgalteriya qiymati Adlai Nortye|ANL - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti adlainortye.com|ANL - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Barcha qarzlarning o‘z mablag‘lariga nisbati Adlai Nortye Ltd.|ANL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Adlai Nortye Limited|ANL - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Adlai Nortye Ltd.|ANL - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Adlai Nortye|Oraliq qoplash koeffitsiyenti adlainortye.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
ANL - Sof foyda
Kompaniyaning jamlanma tahlili:ANL adlainortye.com
Adlai Nortye Ltd. yetakchi tovari

Ushbu koeffitsient uzoq muddatli majburiyatlarning kapitalga nisbatini o'lchab, biznesning tashqi moliyalashtirishga bog'liqlik darajasini aniqlaydi. Metrikaning tendentsiyasi kompaniyaning kredit risklariga chidamliligini va uning moliyaviy leverajining samaradorligini baholash imkonini beradi. Uzoq muddatli qarzlarning kapitalga nisbatini tahlil qilish orqali investor majburiyatlar tuzilmasining rivojlanishini kuzatishi mumkin. Ushbu ko'rsatkichning pasayishi defolt riskini minimallashtiradi. Barqaror qarz olish Adlai Nortye (ANL) kompaniyasining turli yurisdiksiyalardagi global onkologiya loyihalari pipeline-ining rivojlanishini qo'llab-quvvatlaydi.

Raqobatdosh kompaniyalar

Uzoq muddatli qarzning kapitalga nisbati BeiGene Ltd.|Uzoq muddatli qarzning o'z kapitaliga nisbati Halozyme Inc. (HALO)|Revolution Medicines Corp - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati AAPG (Ascentage Pharma Group)|CGON - Uzoq muddatli qarzning o'z kapitaliga nisbati|UroGen Pharma - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Bicara Therapeutics Inc|Personalis Corp (PSNL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Erasca Oncology - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati DCTH|YMAB: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati AURA|Uzoq muddatli qarzning o'z kapitaliga nisbati candeltx.com CADL|Accuray Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati SELLAS Life Sciences Group, Inc. SLS|ACTU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CTOR (citiusonc.com)|HURA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Protara Therapeutics Inc (TARA)|FATE (Fate Therapeutics Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Aadi Bio|Uzoq muddatli qarzning kapitalga nisbati TCRX|championsoncology.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati XBiotech XBIT|CEL-SCI Corp. - Uzoq muddatli qarzning o'z kapitaliga nisbati|OS Therapies Inc - Uzoq muddatli qarzning kapitalga nisbati|RADX - Uzoq muddatli qarzning kapitalga nisbati|ARTV: Uzoq muddatli qarzning kapitalga nisbati|VERU - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati TPST|XLO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Renovaro Inc. (RENB)|muraloncology.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Kairos Pharma KAPA|OnKure Therapeutics, Inc. (OKUR) - Uzoq muddatli majburiyatlarning kapitalga nisbati|GDTC - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CRIS (Curis, Inc.)|APLM (apollomicsinc.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THAR: Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ADVB|Uzoq muddatli majburiyatlarning kapitalga nisbati genprex.com GNPX|Uzoq muddatli qarzning kapitalga nisbati CLDI|SBFM - Uzoq muddatli majburiyatlarning kapitalga nisbati|Xenetic Biosciences, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SLRX|PPBT - Uzoq muddatli qarzning o'z kapitaliga nisbati|AONC: Uzoq muddatli qarzning o'z kapitaliga nisbati|BGNE (BeiGene) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CKPT: Uzoq muddatli kreditlarning kapitalga nisbati|ELEV (Elevation Oncology, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ICAD (iCAD Corp)|Uzoq muddatli qarzning o'z kapitaliga nisbati IKNA (Ikena Oncology, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati notablelabs.com|Uzoq muddatli qarzning kapitalga nisbati VIRX (Viracta Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati MorphoSys Inc MOR|NAYA - Uzoq muddatli qarzning o'z kapitaliga nisbati|AAPGV (Ascentage) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi